Guidance

National Drugs Control System: user guide

A guide to how to use the National Drugs Control System (NDS) for licence applications for the import and export of controlled drugs and precursor chemicals.

From:
Home Office
Published
16 August 2019
Last updated
2221 June 2022 — See all updates

Documents

National drugs control system 7user webguidance (accessible version)

HTML

National drugs control system user guidance

PDF, 247 KB, 14 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email alternativeformats@homeoffice.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

National drugs control system update, July 2022 (accessible version)

HTML

National drugs control system 7 web update, July 2022

PDF, 533 KB, 6 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email alternativeformats@homeoffice.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The National Drugs Control System (NDS) allows you to make online applications for licences for the import and export of controlled drugs and precursor chemicals.

Licence holders can add preparations and overseas trading partners to their accounts.

This guide gives information on how to:

  • register for an NDS account
  • set up trading partners and preparations
  • apply for import and export licences for controlled drugs and precursor chemicals
  • endorse licences online
Published 16 August 2019
Last updated 2221 June 2022 + show all updates

  1. Removed outdated versions of the guidance.

  2. Added PDF and accessible versions of 'National drugs control system update, July 2022'.

  3. Guidance updated.

  4. First published.